Inventor
AHN SOON-KIL
KR13 patents
⚠️ This page may combine multiple inventors who share the name “AHN SOON-KIL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHONG KUN DANG CORP
5 patentsUS6063812AMay 16, 2000
Fumagillol derivatives and processes for preparing the same
CHONG KUN DANG CORP92 citations95
US6040337AMar 21, 2000
5-demethoxyfumagillol derivatives and processes for preparing the same
CHONG KUN DANG CORP63 citations94
US6034087AMar 7, 2000
Nucleoside derivatives and process for preparing thereof
CHONG KUN DANG CORP7 citations68
US6072051AJun 6, 2000
Nucleoside derivatives and process for preparing the same
CHONG KUN DANG CORP2 citations58
US6310207B1Oct 30, 2001
Process of preparing camptothecin derivatives
CHONG KUN DANG CORP2 citations57
CHONG KUN DANG PHARM CORP
4 patentsUS7718695B2May 18, 2010
Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
CHONG KUN DANG PHARM CORP53 citations96
US8362267B2Jan 29, 2013
Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same
CHONG KUN DANG PHARM CORP2 citations59
US8053439B2Nov 8, 2011
Benzophenone derivatives useful for inhibiting formation of microtubule
CHONG KUN DANG PHARM CORP2 citations58
US6787551B2Sep 7, 2004
Thiazolidinedione derivatives and pharmaceutical composition comprising the same
CHONG KUN DANG PHARM CORP3 citations57
SAMJIN PHARM CO LTD
2 patentsUS12590070B2Mar 31, 2026
Adamantane derivatives as inhibitors of focal adhesion kinase
SAMJIN PHARM CO LTD0 citations44
US10844062B2Nov 24, 2020
Pyridine derivative inhibiting RAF kinase and vascular endothelial growth factor receptor, method for preparing same, pharmaceutical composition containing same, and use thereof
SAMJIN PHARM CO LTD0 citations37